Alterity Therapeutics's market cap is currently $61.99M. The company's EPS TTM is $-0.000663145; its P/E ratio is -10.83; Alterity Therapeutics is scheduled to report earnings on February 28, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.